AI-powered literature monitoring

Automate global and local literature monitoring, eliminate manual pharmacovigilance literature search so your PV team can focus on real patient safety work, not routine.
AI-powered literature monitoring 1

Key Benefits of Our AI-Driven Literature Monitoring Platform

DrugCard unifies global and local publications into one consistent, standardized process. The same workflow, the same quality, and the same reliable automation — whether you track PubMed full texts or local non indexed journal sources.
AI-powered literature monitoring 3

Complete Global & Local Coverage

All medical sources in one platform — from global literature full-text monitoring to 108 countries and 2174+ local sources. Every client gets a tailored source list, country-specific recommendations, and fast addition of any journal without bureaucracy.
AI-powered literature monitoring 4

Higher Impact With the Same Team

Automation removes repetitive literature monitoring so your experts can focus on real PV work — signal detection, risk assessment, drug safety documentation, and scientific evaluation.
AI-powered literature monitoring 5

Zero Missed Publications, Zero Compliance Risk

The platform captures all published articles and scientific literature automatically — no human errors. All results are fully traceable so nothing is overlooked.
AI-powered literature monitoring 6

Full Visibility and Built-In Documentation

You see every task, action, and screening step in real time, eliminating blind spots. DrugCard automatically records all activities, providing complete traceability and ready-to-present audit evidence without manual paperwork.
AI-powered literature monitoring 7

Data Integrity and Security

Your PV data is protected by FDA 21 CFR Part 11–compliant records and signatures, plus a certificate of conformity for use in the EU, US, and CIS. Hosting on ISO/IEC 27001:2013 and SOC 2 Type II infrastructure ensures enterprise-grade security.
AI-powered literature monitoring 8

Always-On Access, Anywhere

As a SaaS solution, DrugCard ensures uninterrupted, 24/7 access on any device. Your work continues smoothly, even across teams, regions, and time zones.
Does this sound like a solution that could help your team right now?
We invite you to experience the benefits of DrugCard with a free 2-week trial.

DrugCard Platform in Numbers

108+
Countries
Medical journals coverage
2174+
Local journals
Continuously monitored
~2
Weeks
New country Easily Added

Comprehensive Feature Set for Literature Screening

AI Article Summaries

Artificial intelligence instantly generates summaries so you can understand the relevant articles’ content without reading the full text.

AI Pre-Assessment of Safety Relevance

Artificial intelligence identifies whether an article contains any safety-relevant references, safety signals, and prioritizes it.

One-Click Case Creation From Literature

Convert an article into an individual case safety report in a single click. Fully integrated with the DrugCard adverse event database.

Automatic Translation of Local Sources

Over 100 supported languages ensure that local literature is just as accessible as global literature — no external translation needed.

Validated, Audit-Ready Platform

Our literature monitoring services successfully passed inspections and audits. Reliability proven by regulatory authorities.

Flexible Project Configuration

Configure literature search projects for any setup — multi-country, multi-client, diverse roles, source lists, and requirements.
AI-powered literature monitoring 12

A Shift From Manual Reading to Automated Medical Literature

The problem with manual screening

Manual literature review consumes hours of repetitive literature surveillance and regulatory reporting, increases the risk of human error and burnout, and makes traceability difficult.

How DrugCard solves it

As the only SaaS tailored to your local and global literature search needs, we offer automated AI relevance checks, summaries, keyword highlighting, weekly reports, and real-time notifications plus continuously expanding coverage.

How It Works

AI-powered literature monitoring 13
AI-powered literature monitoring 13
AI-powered literature monitoring 15
1. Create your project
Select countries, define your coverage (whether it’s global searches, or local publications), and identify the products you want to monitor.
AI-powered literature monitoring 15
2. Get instant results
The system processes sources immediately — no manual runs or waiting time for search results.
AI-powered literature monitoring 13
AI-powered literature monitoring 13
AI-powered literature monitoring 15
3. Stay updated automatically
Receive real-time notifications about new findings and weekly automated reports for full oversight.

Why Leading Pharmacovigilance Teams Choose Us

Teams rely on us for dependable literature surveillance that saves time and supports safety work across all therapeutic areas.

Unmatched Expertise in Literature Screening

Experts in literature review, drug safety, and medicinal products' safety signals — delivering the accuracy your PV processes rely on.

Full Compliance with GVP & Data Security

The system includes all essential controls for GxP activity and good pharmacovigilance practice. You get comprehensive, structured results; role-based user access control; automatic aggregate reports, including search strategy documentation; and a complete audit trail. There’s no need to download or review files manually — the system handles it for you.
AI-powered literature monitoring 20

Have a question?
Just fill out the form and we will contact you within 60 min.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Request a demo
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Contact our sales team!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Book 15 minutes meeting
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for submitting the form.

A dedicated company representative will contact you soon!